scholarly journals Effect of microneedle radiofrequency on scars of transcutaneous lower blepharoplasty

2021 ◽  
Vol 5 (2) ◽  
pp. 99-102
Author(s):  
Hana Kwon ◽  
Hosun Chang ◽  
Ha-Young Kim ◽  
Kyoungjin (Safi)Kang
Keyword(s):  
Lower Blepharoplasty ◽  
Transcutaneous Lower Blepharoplasty

Transcutaneous Lower Blepharoplasty

1996 ◽  
Vol 12 (02) ◽  
pp. 171-183 ◽  
Author(s):  
Peter Adamson ◽  
Harvey Strecker
Keyword(s):  
Lower Blepharoplasty ◽  
Transcutaneous Lower Blepharoplasty

scholarly journals Three Simple Steps for Refining Transcutaneous Lower Blepharoplasty for Aging Eyelids: The Indispensability of Micro-Autologous Fat Transplantation

2019 ◽  
Vol 39 (11) ◽  
pp. 1163-1177 ◽  
Author(s):  
Shu-Hung Huang ◽  
Yun-Nan Lin ◽  
Su-Shin Lee ◽  
Yu-Hao Huang ◽  
Hidenobu Takahashi ◽  
...  
Keyword(s):  
Long Term Results ◽  
Fat Transplantation ◽  
Autologous Fat ◽  
Orbital Fat ◽  
Lower Blepharoplasty ◽  
Tear Trough ◽  
Autologous Fat Transplantation ◽  
The Mean ◽  
Transcutaneous Lower Blepharoplasty

AbstractBackgroundLower blepharoplasty has been used for rejuvenating lower eyelids, and diverse modifications have been used to treat conjunct deformities at the tear trough/lid-cheek junction. Strategies for recontouring prominent tear trough/lid-cheek junctions, including orbital fat manipulation, have been reported with good results in the literature. Micro-autologous fat transplantation (MAFT) is a previously unevaluated, potentially advantageous approach to blending the prominent tear trough/lid-cheek junction.ObjectivesWe determined the long-term results after 3-step transcutaneous lower blepharoplasty with MAFT for patients with aging eyelids and prominent tear trough/lid-cheek junctions.MethodsWe evaluated 205 patients with aging lower eyelids who underwent transcutaneous lower blepharoplasty with MAFT between October 2010 and September 2016. The 3-step procedure involved a subciliary elliptical skin excision, resection of 3 orbital fat compartments, and MAFT for the tear trough/lid-cheek junction employing a MAFT-GUN under intravenous anesthesia.ResultsThe mean patient age was 52 years (range, 34-78 years). The mean operating time was 61 minutes. The mean fat volumes delivered to the tear trough/lid-cheek junctions were 2.80 mL and 2.76 mL for the left and right sides, respectively. The average weights of the 3 resected orbital fat compartments were 0.58 g for the left side and 0.56 g for the right side. Patients showed significant improvement and maintenance at an average follow-up of 60.2 months (range, 18-90 months).ConclusionsThree-step transcutaneous lower blepharoplasty with MAFT is an effective, reliable, and promising method with high patient satisfaction and minimal risk of complications. Long-term results demonstrated its utility for aging lower eyelid treatment.Level of Evidence: 4

Transcutaneous Lower Blepharoplasty with Fat Transposition

2015 ◽  
Vol 42 (1) ◽  
pp. 57-62 ◽  
Author(s):  
Jon-Paul Pepper ◽  
Shan R. Baker
Keyword(s):  
Lower Blepharoplasty ◽  
Transcutaneous Lower Blepharoplasty

Transcutaneous Lower Blepharoplasty

2018 ◽  
pp. 142-151.e1
Author(s):  
Andrew A. Jacono ◽  
Melanie H. Malone
Keyword(s):  
Lower Blepharoplasty ◽  
Transcutaneous Lower Blepharoplasty

Botulinum Toxin to Improve Lower Blepharoplasty Scar: A Double-Blinded, Randomized, Vehicle-Controlled Clinical Trial

2021 ◽  
Author(s):  
Yau-Li Huang ◽  
Christopher Glenn Wallace ◽  
Yen-Chang Hsiao ◽  
Mei-Ching Lee ◽  
Jung-Ju Huang ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Botulinum Toxin ◽  
Visual Analogue Scale ◽  
Analogue Scale ◽  
Vehicle Control ◽  
Reference Points ◽  
Lower Blepharoplasty ◽  
Scar Quality ◽  
Double Blinded ◽  
Transcutaneous Lower Blepharoplasty

Abstract Background Lower blepharoplasty is a common cosmetic operation that relies on minimal postoperative scarring, but Asian patients are at higher risk than Caucasians for hypertrophic and/or widened scars. Botulinum toxin type A (BTX) injections are widely employed to alleviate dynamic facial rhytids and also can improve scar quality by reducing scar tension. The authors assessed whether simultaneous transcutaneous lower blepharoplasty and BTX injections could improve subciliary scar quality. Objectives The objective of this study was to assess whether simultaneous transcutaneous lower blepharoplasty and BTX injections could improve subciliary scar quality. Methods This is a prospective, randomized, vehicle-controlled, double-blinded clinical trial. Between May 2015 and May 2018, 40 adults who underwent bilateral transcutaneous lower blepharoplasties were randomized to receive BTX (n = 20) or vehicle (normal saline; n = 20) injections into the lateral orbicularis oculi muscle immediately after wound closure. Vancouver Scar Scale, Visual Analogue Scale, and photographic scar width measurements at 3 reference points were recorded at the final clinical follow-up. Results Thirty-seven patients completed the trial. Vancouver Scar Scale and Visual Analogue Scale scores in the experimental and vehicle control groups were similar, but scar widths in the experimental group at all measured points were significantly narrower than in the vehicle control group (P < 0.001, P = 0.027, and P < 0.001 at each measured point, respectively). Conclusions Transcutaneous lower blepharoplasty scars in Asians can be significantly narrowed by simultaneous BTX injections without additional complications. Level of Evidence 4

Sign in / Sign up

Export Citation Format

Share Document